These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38654047)

  • 21. Identification of a Nuclear Mitochondrial-Related Multi-Genes Signature to Predict the Prognosis of Bladder Cancer.
    Jiang X; Xia Y; Meng H; Liu Y; Cui J; Huang H; Yin G; Shi B
    Front Oncol; 2021; 11():746029. PubMed ID: 34692528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and validation of a novel mitochondrion-related gene signature for diagnosis and immune infiltration in sepsis.
    Hao S; Huang M; Xu X; Wang X; Song Y; Jiang W; Huo L; Gu J
    Front Immunol; 2023; 14():1196306. PubMed ID: 37398680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Construction and validation of a bladder cancer risk model based on autophagy-related genes.
    Shen C; Yan Y; Yang S; Wang Z; Wu Z; Li Z; Zhang Z; Lin Y; Li P; Hu H
    Funct Integr Genomics; 2023 Jan; 23(1):46. PubMed ID: 36689018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New insights into the role of mitochondrial metabolic dysregulation and immune infiltration in septic cardiomyopathy by integrated bioinformatics analysis and experimental validation.
    Li Y; Yu J; Li R; Zhou H; Chang X
    Cell Mol Biol Lett; 2024 Jan; 29(1):21. PubMed ID: 38291374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling.
    Kawakami K; Enokida H; Tachiwada T; Gotanda T; Tsuneyoshi K; Kubo H; Nishiyama K; Takiguchi M; Nakagawa M; Seki N
    Oncol Rep; 2006 Sep; 16(3):521-31. PubMed ID: 16865252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpressed KCNK1 regulates potassium channels affecting molecular mechanisms and biological pathways in bladder cancer.
    Zhang W; Chen XS; Wei Y; Wang XM; Chen XJ; Chi BT; Huang LQ; He RQ; Huang ZG; Li Q; Chen G; He J; Wu M
    Eur J Med Res; 2024 Apr; 29(1):257. PubMed ID: 38689322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of cell division cycle 20 as a candidate biomarker and potential therapeutic target in bladder cancer using bioinformatics analysis.
    Shen P; He X; Lan L; Hong Y; Lin M
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32677673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Four novel biomarkers for bladder cancer identified by weighted gene coexpression network analysis.
    Yan X; Guo ZX; Liu XP; Feng YJ; Zhao YJ; Liu TZ; Li S
    J Cell Physiol; 2019 Aug; 234(10):19073-19087. PubMed ID: 30927274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrative transcriptional characterization of cell cycle checkpoint genes promotes clinical management and precision medicine in bladder carcinoma.
    Shi WW; Guan JZ; Long YP; Song Q; Xiong Q; Qin BY; Ma ZQ; Hu Y; Yang B
    Front Oncol; 2022; 12():915662. PubMed ID: 36033441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of immune-related genes as prognostic factors in bladder cancer.
    Zhu J; Wang H; Ma T; He Y; Shen M; Song W; Wang JJ; Shi JP; Wu MY; Liu C; Wang WJ; Huang YQ
    Sci Rep; 2020 Nov; 10(1):19695. PubMed ID: 33184436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpressed VDAC1 in breast cancer as a novel prognostic biomarker and correlates with immune infiltrates.
    Fang Y; Liu J; Zhang Q; She C; Zheng R; Zhang R; Chen Z; Chen C; Wu J
    World J Surg Oncol; 2022 Jun; 20(1):211. PubMed ID: 35729567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a Prognosis-Related Risk Signature for Bladder Cancer to Predict Survival and Immune Landscapes.
    Wang L; Wang Y; Wang J; Li L; Bi J
    J Immunol Res; 2021; 2021():3236384. PubMed ID: 34708131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hsa_circ_0001944 promotes the growth and metastasis in bladder cancer cells by acting as a competitive endogenous RNA for miR-548.
    Jin M; Lu S; Wu Y; Yang C; Shi C; Wang Y; Huang G
    J Exp Clin Cancer Res; 2020 Sep; 39(1):186. PubMed ID: 32928266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Machine-learning algorithm-based prediction of a diagnostic model based on oxidative stress-related genes involved in immune infiltration in diabetic nephropathy patients.
    Zhu HM; Liu N; Sun DX; Luo L
    Front Immunol; 2023; 14():1202298. PubMed ID: 37554330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urine micro-RNA signature as a potential non-invasive diagnostic biomarker in bladder cancer.
    Mamdouh S; Sherif H; Romeih M; Elesaily K
    Asian Pac J Cancer Prev; 2023 Jan; 24(1):121-131. PubMed ID: 36708560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer.
    Wang Z; Tu L; Chen M; Tong S
    BMC Cancer; 2021 Jun; 21(1):692. PubMed ID: 34112144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying stage-associated hub genes in bladder cancer via weighted gene co-expression network and robust rank aggregation analyses.
    Feng F; Zhong YX; Huang JH; Lin FX; Zhao PP; Mai Y; Wei W; Zhu HC; Xu ZP
    Medicine (Baltimore); 2022 Dec; 101(51):e32318. PubMed ID: 36595851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and validation of novel biomarkers affecting bladder cancer immunotherapy
    Wang J; He X; Bai Y; Du G; Cai M
    Front Immunol; 2022; 13():1051063. PubMed ID: 36439109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and validation of a novel signature for prediction the prognosis and immunotherapy benefit in bladder cancer.
    Zhang Y; Lin Y; Lv D; Wu X; Li W; Wang X; Jiang D
    PeerJ; 2022; 10():e12843. PubMed ID: 35127296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a novel metabolism-related gene signature associated with the survival of bladder cancer.
    Li X; Fu S; Huang Y; Luan T; Wang H; Wang J
    BMC Cancer; 2021 Nov; 21(1):1267. PubMed ID: 34819038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.